AMRUTANJANPharmaceuticals
Amrutanjan Health Care Ltd — Cash Flow Statement
₹493.65
-1.89%
Amrutanjan Health Care Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 15.35 Cr | 21.19 Cr | 11.25 Cr | 28.73 Cr | — |
| Repurchase Of Capital Stock | 0.00 | -28.80 Cr | 0.00 | — | -0.96 Cr |
| Issuance Of Capital Stock | 0.24 Cr | 1.18 Cr | 0.00 | -3.53 Cr | — |
| Capital Expenditure | -35.55 Cr | -6.72 Cr | -8.93 Cr | -23.46 Cr | — |
| End Cash Position | 10.16 Cr | 3.71 Cr | 4.90 Cr | 2.19 Cr | — |
| Beginning Cash Position | 3.71 Cr | 4.90 Cr | 2.19 Cr | 2.91 Cr | — |
| Effect Of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | -2000.00 | — |
| Changes In Cash | 6.44 Cr | -1.19 Cr | 2.72 Cr | -0.72 Cr | — |
| Financing Cash Flow | -13.49 Cr | -48.27 Cr | -14.99 Cr | -16.70 Cr | — |
| Cash Dividends Paid | -13.27 Cr | -13.39 Cr | -14.41 Cr | -12.48 Cr | — |
| Net Common Stock Issuance | 0.24 Cr | -27.62 Cr | 0.00 | -3.53 Cr | — |
| Common Stock Payments | 0.00 | -28.80 Cr | 0.00 | — | -0.96 Cr |
| Common Stock Issuance | 0.24 Cr | 1.18 Cr | 0.00 | -3.53 Cr | — |
| Investing Cash Flow | -30.97 Cr | 19.16 Cr | -2.48 Cr | -36.21 Cr | — |
| Interest Received Cfi | 16.05 Cr | 14.12 Cr | 11.23 Cr | 12.63 Cr | — |
| Net Investment Purchase And Sale | -11.46 Cr | 11.50 Cr | -4.82 Cr | -25.38 Cr | — |
| Sale Of Investment | 5000.00 | 11.50 Cr | 7.50 Cr | 4.82 Cr | — |
| Purchase Of Investment | -11.46 Cr | — | -12.32 Cr | -30.21 Cr | -91.53 Cr |
| Net PPE Purchase And Sale | -35.55 Cr | -6.46 Cr | -8.88 Cr | -23.46 Cr | — |
| Sale Of PPE | 0.00 | 0.26 Cr | 0.04 Cr | 0.00 | — |
| Purchase Of PPE | -35.55 Cr | -6.72 Cr | -8.93 Cr | -23.46 Cr | — |
| Operating Cash Flow | 50.90 Cr | 27.91 Cr | 20.18 Cr | 52.20 Cr | — |
| Taxes Refund Paid | -17.92 Cr | -16.50 Cr | -16.06 Cr | -24.19 Cr | — |
| Change In Working Capital | 9.02 Cr | -10.19 Cr | -9.64 Cr | -3.93 Cr | — |
| Change In Other Current Liabilities | 1.17 Cr | 0.22 Cr | -1.33 Cr | 2.01 Cr | — |
| Change In Other Current Assets | -0.86 Cr | -2.37 Cr | 0.22 Cr | -1.26 Cr | — |
| Change In Payable | 14.62 Cr | 9.54 Cr | -10.67 Cr | 23.68 Cr | — |
| Change In Inventory | 1.64 Cr | -0.08 Cr | -2.82 Cr | -8.54 Cr | — |
| Change In Receivables | -8.20 Cr | -16.97 Cr | 4.77 Cr | -20.99 Cr | — |
| Other Non Cash Items | -15.83 Cr | -14.69 Cr | -11.71 Cr | -10.69 Cr | — |
| Stock Based Compensation | 1.15 Cr | 0.21 Cr | 0.44 Cr | -0.01 Cr | — |
| Provisionand Write Offof Assets | -1.18 Cr | 0.96 Cr | -1.95 Cr | -3.50 Cr | — |
| Depreciation And Amortization | 6.53 Cr | 6.06 Cr | 5.21 Cr | 3.80 Cr | — |
| Depreciation | 6.53 Cr | 6.06 Cr | 4.42 Cr | 3.66 Cr | — |
| Gain Loss On Investment Securities | -20000.00 | 0.13 Cr | 0.20 Cr | 0.14 Cr | — |
| Gain Loss On Sale Of PPE | 0.00 | -0.16 Cr | -0.03 Cr | 0.00 | — |
| Net Income From Continuing Operations | 69.13 Cr | 61.95 Cr | 53.65 Cr | 90.58 Cr | — |
| Net Other Financing Charges | — | -6.70 Cr | — | — | -0.96 Cr |
| Amortization Cash Flow | — | 0.85 Cr | 0.79 Cr | 0.14 Cr | 0.17 Cr |
| Interest Paid Cff | — | — | — | 0.00 | -0.03 Cr |
| Net Foreign Currency Exchange Gain Loss | — | — | — | 0.00 | -0.05 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Amrutanjan Health Care Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.